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Background: The measure of disease frequency most widely used to report healthcare-
associated infection (HAI) is the point-prevalence survey. Incidence studies are rarely
performed due to time and cost constraints; they show which patients are affected by HAI,
when and where, and inform planning and design of infection prevention and control (IPC)
measures.
Aim: To determine the epidemiology of HAI within a general and a teaching hospital in
Scotland.
Methods: A prospective observational incidence study was undertaken for one year from
April 2018 using data collected as part of the Evaluation of Cost of Nosocomial Infection
(ECONI) study. A novel, robust approach was undertaken, using record linkage to national
administrative data to provide full admission and discharge information. Cases were
recorded if they met international HAI definitions.
Findings: Incidence of HAI for the combined hospitals was 250 HAI cases per 100,000 acute
occupied bed-days (AOBD). Highest frequency was in urinary tract (51.2 per 100,000
AOBD), bloodstream (44.7), and lower respiratory tract infection (42.2). The most fre-
quently reported organisms were Escherichia coli, Staphylococcus aureus, and norovirus.
Incidence of HAI was higher in older people and emergency cases. There was an increase in
the rate of HAI in summer months (pneumonia, respiratory, surgical, and gastrointestinal
infection) and in winter months norovirus gastrointestinal infection (P < 0.0001). TheCaledonian University,
: þ44 (0)1413 313536.
S. Stewart).
on behalf of The Healthcare Infection Society.
S. Stewart et al. / Journal of Hospital Infection 114 (2021) 10e22 11highest incidence specialties were intensive care, renal medicine, and cardiothoracic
surgery. HAI occurred at a median of 9 days (interquartile range: 4e19) after admission.
Incidence data were extrapolated to provide an annual national estimate of HAI in NHS
Scotland of 7437 (95% confidence interval: 7021e7849) cases.
Conclusion: This study provides a unique overview of incidence of HAI and identifies the
burden of HAI at the national level for the first time. Understanding the incidence in
different clinical settings, at different times, will allow targeting of IPC measures to those
patients who would benefit the most.
ª 2021 Published by Elsevier Ltd on behalf of The Healthcare Infection Society.Introduction
Healthcare-associated infection (HAI), especially those
caused by antimicrobial-resistant pathogens, is an area of
public health concern throughout the world. The World Health
Organization estimates that HAI is the most frequently occur-
ring adverse event in any healthcare system regardless of
available resources [1]. There is evidence that many HAIs are
avoidable and cause longer hospital stays and distress to
patients [2e5].
The measure of disease frequency most commonly used to
report HAI is the point-prevalence survey (PPS); these studies
report the proportion of the population who have HAI at a given
point in time. Within Europe it is estimated that 6.5% of
patients treated within an acute care hospital have an HAI at
the time of survey [6]. In Scotland in 2016 the overall point
prevalence of HAI was 4.5% of acute hospital patients [7].
Although prevalence of HAI in 2016 was lower than that
reported five years previously there remains the potential to
reduce the number of patients affected [7e9]. Point-
prevalence surveys are helpful for estimating the burden of
disease, but longer duration incidence surveillance gives more
comprehensive information on risk of developing HAI. Whereas
incidence studies are rarely done due to time and cost con-
straints, they show which patients are affected by HAI, when
and where, and inform planning and design of infection pre-
vention and control (IPC) measures.
The aim of this study was to determine the incidence, HAI
type, and the distribution of HAI within the study hospitals; we
also report the time, place, and person characteristics affec-
ted by HAI. A national estimate of incidence of HAI was cal-
culated by extrapolating the incidence found within the study
hospitals.Methods
The Evaluation of Cost of Nosocomial Infection (ECONI)
study reports a two-centre, prospective, observational inci-
dence study supplemented with hospital record linkage to
provide full admission and discharge information on non-cases
[10]. The participating hospitals were selected as being broadly
representative of other acute hospitals in Scotland in terms of
patient specialties, distribution of elective, emergency, and
transfers, mean length of stay, previously reported HAI prev-
alence, patient mix, and rurality. Data were collected from
June 28th, 2018 until June 27th, 2019 in the general hospital and
from April 23rd, 2018 until April 22nd, 2019 in the teachinghospital [8,11,12]. Data sources for the study are listed in
Appendix A, Table A.1. The large teaching hospital had 981
beds including 16 general and nine cardiothoracic intensive
care beds and 13 general, eight cardiothoracic and 12 trans-
plant and renal high-dependency beds; the large general hos-
pital had 492 beds including five intensive care and four high-
dependency beds [10,13]. In 2015/16 when the study was
planned the average beds were 886 (range: 711e1046) for the
seven teaching hospitals and 479 (range: 245e57) for the 15
large general hospitals within NHS Scotland [12]. Mean length
of stay (LOS) was 4.7 days overall in NHS Scotland, within the
teaching hospital the mean LOS was 4.4 days and within the
general hospital was 4.1 days. The teaching hospital had 831
available acute beds during the reporting period 2018/19,
when data collection for the study took place, and the general
hospital 418 [14]. The hospitals offered 91% of all specialties
served within Scotland in 2016 when the study was being
planned.Case definitions
HAI was defined as an infection arising48 h after admission
to hospital and not present or incubating on admission, unless
the patient had been discharged from hospital within a defined
period. An incident HAI was defined by microbiologically con-
firmed European Centre for Disease Prevention and Control
(ECDC) HAI epidemiological case definitions [15]. These defi-
nitions categorize HAI according to the organ/tissue system
affected and have been adopted for use within Europe and
internationally. Selected antimicrobial susceptibility testing
data were recorded for micro-organisms recovered from HAI
samples (see Appendix A, Table A.2). In NHS Scotland the
European Committee on Antimicrobial Susceptibility Testing
definitions of antibiotic susceptibility are used in all clinical
laboratories including the two study hospitals [16].Study design
The study team collected data on all adult overnight
admissions that met the case definitions during the study
period. Suspected HAI cases were identified by trained
research nurses using the laboratory systems and cases were
ascertained using case note review. Cases which met the ECDC
HAI case definitions were recorded on a bespoke REDCap
database [17]. This data set included HAI type, date of onset,
causative organism, and selected antibiotic susceptibilities
along with the patients’ Community Health Index number (CHI)
S. Stewart et al. / Journal of Hospital Infection 114 (2021) 10e2212according to the ECONI study protocol [10,18]. All isolates were
recorded for each HAI and this provided a greater number of
organisms than HAIs. Data linkage with NHS Scotland admin-
istrative data created a novel dataset on all adult overnight
admissions to study hospitals to make the study more com-
prehensive. Day cases were excluded.Statistical analysis
The incidence of HAI for each specialty and type of HAI was
calculated as the number of HAI per 100,000 acute occupied
bed-days (AOBD). The total number of bed-days occupied was
derived from the Scottish Morbidity Record (SMR01), which is
an episode-based record relating to all inpatients in NHS
Scotland [19].Temporal trend test
The incidence of new cases of HAI was calculated per
100,000 AOBD for each calendar month. c2-Test was used to
assess whether the rates of HAI types were constant each
month during the study. Additional data from the study period
allowed calculation of the overall rate of each HAI type per
admission episode. The expected numbers of HAI types each
month were obtained from the admission episode and com-
pared with observed numbers in each month.Deriving national estimates for HAI incidence
Incidence rates of HAI per 100,000 AOBD, identified in the
ECONI incidence study according to ECDC case definitions,
were used to provide an overall estimate of HAI incidence for
NHS Scotland [15]. Incidence of HAI (per 100,000 AOBD) varies
by both hospital type and specialty. National estimates of the
number of HAIs were derived by applying the incidence within
each specialty group and hospital type [20]. This incidence rate
was then applied to the total annual overnight admissions
within NHS Scotland. Hospitals classified as children’s hospitals
were excluded from this extrapolation, as no information was
available for these hospital types. The extrapolation was vali-
dated by estimating the total number of HAIs using total bed-
days only and total bed-days and hospital type.Table I







Lower respiratory tract infection 42.2
Pneumonia 23.5
Surgical site infection 35.3
Urinary tract infection 51.2
Othera 13.6
a Low-number infections, including skin soft tissue, bone and joint, ca
infections made up 3% of the total HAIs but within this group there was a wEthics
This study was surveillance and therefore was confirmed as
ineligible for ethical review (Bailey A. Personal communication
to S. Stewart, September 8th, 2016. SouthEast ScotlandResearch
Ethics Service). It was approved by national information gover-
nance approvals: Public Benefit of Health and Social Care: Inci-
dence study: 1617-0037.
Results
Quantifying HAI in the in-hospital population:
incidence and type of HAI
During the study period there were 99,018 adult overnight
admissions: 31,655 to the general hospital and 67,363 to the
teaching hospital. Different patterns of HAI incidence were seen
in the two hospital settings. In the general hospital 87 cases of
HAI were identified (0.28% of admissions) and there were 996 in
the teachinghospital (1.48%ofadmissions).Overall, 893patients
had one or more HAI during their stay in hospital. A total of
135,831 bed-days were occupiedwithin the general hospital and
298,003 bed-days in the teaching hospital. Incidence of HAI was
64 per 100,000 AOBD in the general hospital and 334 per 100,000
AOBD in the teaching hospital, with an overall incidence for the
combined hospitals of 250 per 100,000 AOBD.
Themost frequently identified HAI types in the two hospitals
were urinary tract infection (UTI) (51.2 per 100,000 AOBD),
followed by bloodstream infection (BSI) (44.7 per 100,000
AOBD) (Table I). Combined respiratory tract infections (pneu-
monia: 23.5; lower respiratory tract infection (LRI): 42.2) were
greater than UTI at 65.7 per 100,000 AOBD but these repre-
sented a wider range of illness severity. The rate of surgical site
infection (SSI) was 35.3 per 100,000 AOBD and gastrointestinal
infection (GI) rate was 39.2 per 100,000 AOBD. Of all HAI, 6.5%
were defined as part of an outbreak [21].
Micro-organisms isolated from patients with HAI
Of the HAIs reported, 96.6% had an organism isolated, with
118 different species identified. A total of 1314 organisms were
isolated from 1083 HAIs (Table II). Overall, the most frequently
isolated bacterial species was Escherichia coli (18.4%),ute occupied-bed-days (1083 cases of HAI within the two hospitals)












rdiovascular, eyeeearenoseethroat, and systemic infections. These
ide range of organs affected by this diverse group of HAIs.
Table II
Percentage of organisms identified by HAI type, for teaching and general hospitals combined
Organism/group BSI % HAI type
GI LRI PN SSI UTI Other Total
Gram-positive cocci 45.49 23.47 14.16 15.52 56.36 17.09 66.13 32.05
Staphylococcus aureus 14.75 1.02 8.41 8.62 22.46 1.28 30.65 10.81
Streptococcus spp. 6.56 1.02 2.20 3.45 2.53 0.43 4.84 2.82
Gram-positive cocci other 0.82 0.00 0.44 0.00 0.42 0.00 0.00 0.30
Coagulase-negative staphylococci 6.15 5.10 1.33 0.86 15.68 1.28 22.58 6.32
Enterococcus faecalis 8.61 5.10 1.33 1.72 10.17 1.28 4.84 5.02
Enterococcus faecium 7.79 8.16 0.44 0.86 4.24 3.85 1.61 4.34
Other Enterococcus sp. 0.82 3.06 0.00 0.00 0.85 8.97 1.61 2.44
Gram-negative cocci 0.82 0.51 13.27 10.34 0 0 0 3.42
Gram-positive bacilli 0.41 19.39 0.44 2.59 3.39 0 1.61 3.96
Clostridium difficile 0 18.88 0 0 0 0 0 2.82
Clostridium perfringens 0.41 0 0 0 0 0 0 0.08
Gram-positive bacilli other 0 0.51 0.44 2.59 3.39 0 1.61 1.07
Gram-negative bacilli 51.23 11.73 23.89 26.72 31.36 75.21 11.29 37.29
Escherichia coli 26.64 5.1 7.08 9.48 11.02 48.72 0 18.42
Klebsiella spp. 3.69 0 3.98 4.31 3.39 1.28 0 2.59
Klebsiella pneumoniae 6.15 1.53 3.1 4.31 2.97 8.12 1.61 4.34
Morganella morganii 0.41 0 0 0 1.27 0.85 0 0.46
Proteus mirabilis 1.64 0 1.33 0.86 2.54 9.4 0 2.74
Proteus spp. 0.41 0 0.44 0 1.27 0 0 0.38
Serratia marcescens 2.46 0 3.1 1.72 2.12 0.85 0 1.67
Other Enterobacterales 5.33 1.53 2.21 1.72 2.56 1.69 1.61 2.59
Acinetobacter spp. 1.64 0 0 0 0 0 1.61 0.38
Pseudomonas spp. 1.23 0.51 1.77 3.45 2.54 3.42 1.61 2.05
Other non-Enterobacterales 1.64 3.06 0.88 0.86 2.54 0 4.84 1.67
Viruses 0 40.31 36.73 29.31 0 0 8.06 15.3
Influenza 0 0 15.04 5.17 0 0 0 3.04
Parainfluenza virus 0 0 4.42 1.72 0 0 0 0.91
Norovirus 0 39.8 0 0 0 0 0 5.94
Rhinovirus 0 0 3.1 5.17 0 0 1.61 1.07
Human coronavirusa non-outbreak 0 0 2.65 6.9 0 0 0 1.07
Human metapneumovirus virus 0 0 2.65 3.45 0 0 0 0.76
Respiratory syncytial virus 0 0 5.75 3.45 0 0 0 1.29
Herpes simplex virus 0 0 1.77 1.72 0 0 4.84 0.68
Other virus 0 0.51 1.33 1.72 0 0 1.61 0.53
Fungi 2.05 2.55 11.5 15.52 6.78 7.69 12.9 7.31
Candida albicans 0.82 1.02 1.77 4.31 1.69 1.28 9.68 1.98
Candida other 1.23 1.53 6.64 7.76 3.39 5.98 1.61 4.03
Aspergillus spp. 0 0 1.33 2.59 0.85 0 1.61 0.68
Other fungi 0 0 1.77 0.86 0.85 0.43 0 0.61
Other 0 2.04 0 0 2.12 0 0 0.68
HAI, healthcare-associated infection; BSI, bloodstream infection; GI, gastrointestinal infection; LRI, lower respiratory tract infection; PN, pneu-
monia; SSI, surgical site infection; UTI, urinary tract infection.
The table reports the organisms identified by samples relating to each organ space. There are more confirmed organisms (1314) than the total
number of HAIs (1083).
a Common type, not COVID-19 (Human.coronavirus.229E, Human.coronavirus.NL63, Human.coronavirus.OC43).
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Enterococcus faecium (4.3%), Klebsiella pneumoniae (4.3%),
and Clostridioides difficile (2.8%). Among isolates examined,
15.3% were viruses (of all organisms identified influenza
accounted for 3.0% of the total and norovirus 5.9%). Gram-
negative bacilli were identified in 51% of all organisms from
BSI, 91% of which were Enterobacterales. Gram-negative bacilli
also comprised 75% of all organisms causing UTI. E. colirepresented 48.7% of all UTI organisms and 26.6% of isolates
from BSI. Candia albicans only represented 2% of overall iso-
lates, but these were associated with 4.3% of isolates from
pneumonia cases. Seventy of 1083 HAIs were classed as part of
an outbreak [21]. Meticillin-resistant S. aureus (according to
oxacillin resistance) was seen in 7.1% of S. aureus isolated from
HAI. No antibiotic resistance was seen for S. pneumoniae or b-
haemolytic streptococci (Table III).
Table III
Antibiotic susceptibilities of isolates by organism










Staphylococcus aureus Oxacillin 142 140 130 10 7.1%
Teicoplanin 142 133 133 0 0
Vancomycin 142 133 133 0 0
Streptococcus pneumoniae Penicillin 6 6 6 0 0
Co-amoxiclav 6 5 5 0 0
Ciprofloxacin 6 5 5 0 0
b-Haemolytic streptococcus
(Group A/B/C)
Penicillin 10 9 9 0 0
Co-amoxiclav 10 4 4 0 0
Ciprofloxacin 10 4 4 0 0
Enterococcus faecalis Amoxicillin 66 58 50 8 14%
Teicoplanin 66 55 53 2 4%
Vancomycin 66 62 51 11 18%
Enterococcus faecium Amoxicillin 57 54 6 48 89%
Teicoplanin 57 52 17 35 67%
Vancomycin 57 56 16 40 71%
Escherichia coli Co-amoxiclav 242 237 115 122 51.5%
Amoxicillin 242 239 87 152 63.6%
Ceftazidime 242 234 213 21 9.0%
Ciprofloxacin 242 236 201 35 14.8%
Ceftriaxone 242 213 197 16 7.5%
Gentamicin 242 236 224 12 5.1%
Meropenem 242 236 236 0 0
Piperacillin/tazobactam 242 235 216 19 8.1%
Klebsiella pneumoniae Co-amoxiclav 57 56 45 11 19.6%
Amoxicillin 57 56 2 54 96.4%
Axtreonam 57 53 50 3 5.7%
Ceftazidime 57 56 51 5 8.9%
Ciprofloxacin 57 56 48 8 14.3%
Ceftriaxone 57 52 48 4 7.7%
Gentamicin 57 56 54 2 3.6%
Meropenem 57 56 56 0 0
Piperacillin/tazobactam 57 55 48 7 12.7%
Acinetobacter spp. Ciprofloxacin 5 5 5 0 0
Gentamicin 5 5 5 0 0
Pseudomonas aeruginosa Ciprofloxacin 26 25 23 2 8.0%
Levofloxacin 26 0 0 0 0
Meropenem 26 25 22 3 12.0%
Piperacillin/tazobactam 26 25 19 6 24.0%
Pseudomonas spp. Ciprofloxacin 27 26 24 2 7.7%
Ceftriaxone 27 0 0 0 0
Levofloxacin 27 0 0 0 0
Meropenem 27 26 23 3 11.5%
Piperacillin/tazobactam 27 26 20 6 23.1%
Meropenem 5 1 1 0 0
S. Stewart et al. / Journal of Hospital Infection 114 (2021) 10e2214Origin of HAI
The presence of invasive devices before the onset of HAI was
recorded for pneumonia, UTI and BSI (Table IV). Healthcare-
associated pneumonia was associated with intubation in
40.2% of cases. UTI was associated with the presence of a uri-
nary catheter in 37.8% of cases. Of BSI patients, 95.2% had a
vascular catheter placement 48 h before the onset of their BSI.
Of all BSI cases, 7.3% were assumed to be catheter-related,
since phenotypically related organisms were isolated from
catheter and blood. A primary infection source was identifiedfor 16.5% of BSIs; the most common of these were UTIs (5.8% of
total BSI) and GIs (5.8%).
Person: patient characteristics
Patients who developed HAI tended to be older, with 28% of
all HAI found in patients aged >80 years and 71% of all HAI in
patients aged >60 years. More HAIs occurred in patients who
were admitted as emergency cases rather than as elective
cases. Emergency cases made up 80.5% of all patients admitted
to the study hospitals. There was no obvious trend in incidence
Table IV
Characteristics of HAIs, associated with invasive device use, origin





Total no. of HAIs 1083 100%
Place where HAI became active
HAIs present on admission 55 5.1%
Origin: same hospital 28 50.9%
Other Scottish NHS hospital 21 38.2%
Other hospital outside Scotland 6 10.9%
HAI onset during current admission 1028 94.9%
Day of HAI onseta
Known date of admission 1050
Day 1e2 117 10.8%
Day 3e4 124 11.4%
Day 5e7 180 16.6%
Day 8e14 225 20.8%
Day 15e21 113 10.4%
Post day 21 291 26.9%
Unable to obtain the date of admission 33 3.0%
Device-associated HAI
Pneumonia totalb 102 9.4%
Intubation 48 h before onset 41 40.2%
No intubation 61 59.8%
Urinary tract infections total 222 20.5%
Urinary catheter 7 days before of onset 84 37.8%
No urinary catheter 138 62.2%
Bloodstream infections 206 19.0%
Vascular catheter 48 h before onset 196 95.15%
No vascular catheter 10 4.85%
Origin of bloodstream infections (BSI)
Total BSIc 206 100%
Catheter-related BSId 15 7.3%
CVCe 13 6.3%
PVCf 2 1.0%
Source/primary infections linked to BSIg 34 16.5%
Pulmonary infection 4 1.94%
Urinary tract infection 12 5.83%
Surgical site infection 5 2.43%
Gastrointestinal tract infection 12 5.83%
Other infection sites 1 0.49%
Unknown originh 157 76.21%
BSI, bloodstream infection; CVC, central vascular catheter; PVC,
peripheral vascular catheter; CRI, catheter-related infection (with
positive catheter tip microbiological results, see case definitions);
CRI3, CRI with positive blood culture.
a HAIs with onset during current hospitalization only. Number of HAIs
(1050): starting from 1083 infections, 33 cases were excluded (10 did
not have a CHI number which indicates that the patients were not
resident in Scotland; 7 were not linked; 16 onset not within continuous
inpatient stay).
b Includes pneumonia subcategories PN1ePN5.
c Total BSI (including CRI3).
d % catheter-related BSI (CRI3: CRI with positive blood culture).
e % of total BSIc which is central vascular catheter-related.
f % of total BSIc which is peripheral vascular catheter-related.
g BSI secondary to another infection site.
h BSI origin was verified and confirmed to be unknown.
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quintiles [22]. Appendix A, Table A.3 shows the characteristics
of all admissions to the combined ECONI study hospitals. A total
of 99,018 admission episodes to the study hospitals were
included within the analysis.
Place: specialty of treatment
The highest HAI incidences by AOBD were for patients in
intensive care units (ICUs) and high-dependency units (HDUs);
most of these were in the respiratory tract (LRI and pneumonia)
(Figure 1). ICU/HDU is a relatively small specialty in terms of
total occupied bed-days within the study hospitals (9338) and
the total number of HAIs (123 cases) was approximately half
(54%) of the cases found in general surgery (226 cases). The
second highest incidence was in renal medicine followed by
cardiothoracic surgery. Renal medicine showed the highest
incidence of BSI. In terms of total numbers, the specialties of
general surgery, general medicine trauma and orthopaedic
surgery and geriatric medicine (short and long stay) treat 59%
of all HAI patients in the hospitals (Figure 1). These specialties
have a large number of occupied bed-days and despite the
actual numbers of HAI being relatively high the incidence of HAI
is low. General medicine had the greatest number of admis-
sions overall, but incidence is relatively low per AOBD (123.7
per 100,000 AOBD), which is lowest when the specialties are
ranked from highest to lowest.
Time: when do HAIs occur?
There was an increase in the rate of HAI in summer months
of June and July (P< 0.0001), largely associated with increased
rates of pneumonia, LRI, SSI, and GI (Figure 2). BSI and com-
bined ‘other’ infections did not exhibit a seasonal pattern.
There were also winter peaks in the proportion of GI, which was
mainly caused by norovirus in December and January.
HAI events occurred a median of 9 days (IQR: 4e19) after
admission to hospital. A total of 40.1% of HAI occurred within
seven days of admission (Figure 2). Just over one in ten HAIs
(11.1%) occurred within 3 days of admission to hospital. The
largest proportion of these (42.0%) were SSI, which may arise
and meet the case definitions at any point up to 30 days post
surgery for surgery with no implant and 90 days if surgery
involves an implant.
National estimates for NHS Scotland
When the ECONI data was extrapolated for all admissions to
hospital in NHS Scotland, the estimated annual number of HAI
in teaching and general hospitals in Scotland was 7437 (95%
confidence interval: 7021e7849). This extrapolation was based
on the incidence within each specialty shown in Table I and the
total AOBD within each specialty in NHS Scotland annually. This
approach shown in Table V was selected as it takes account of
the variation in incidence of HAI in both hospital and specialty
type. When all HAI was extrapolated using total available beds,
rather than varying the incidence by specialty of the occupied



































































































































































Figure 1. Incidence of HAI by specialty and distribution of HAI types by specialty. AOBD, acute occupied bed-days; ITU, intensive therapy
unit; HDU, high-dependency unit; HAI, healthcare-associated infection; BSI, bloodstream infection; GI, gastrointestinal infection; LRI,
lower respiratory tract infection; PN, pneumonia; SSI, surgical site infection; UTI, urinary tract infection.
S. Stewart et al. / Journal of Hospital Infection 114 (2021) 10e2216the total number of annual HAIs in Scotland was estimated to
be 10,594. When annual incidence was calculated based on
total hospital beds but accounting for hospital type, i.e. higher
incidence rate within teaching hospitals and lower within
general hospitals, the estimate was 8438 HAIs per year.
Discussion
This is the first study of HAI incidence in the UK in more than
20 years [23]. Such studies are rarely done because they are
resource intensive and the last decade has seen PPS predom-
inate hospital surveillance across the globe as the main
approach to estimating burden [24,25]. However, PPSs are
limited, associations and risk are temporal, and biases mean
that these results have been overinterpreted and may have
resulted in overestimation of the true burden. Furthermore,
there are limited opportunities to examine risk factors. This
study provides unique insight into national HAI rates, with
novel whole-hospital incidence data and record linkage data to
make it more robust. The findings have international sig-
nificance, since the focus of most countries in the last decade
has been prevalence surveys to inform burden estimates andIPC planning. The study also has international implications for
future planning of PPS and other surveillance studies. The HAI
incidence was lower than previously reported, with an inci-
dence rate of 64 per 100,000 AOBD in the general hospital and
334 per 100,000 AOBD in the teaching hospital, with an overall
incidence for the combined hospitals of 250 per 100,000 AOBD.
These estimates indicate that the annual HAI incidence in
acute care in NHS Scotland was approximately one in every 100
patients (7437 HAIs/year). This is lower than the reported
estimated incidence from prevalence studies published to date
(55,307), which converted prevalence to incidence using an
estimated duration of infection based on date of admission and
date of survey [7,26]. The ECDC used another variation on the
Rhame equation to estimate an overall incidence in NHS Scot-
land of 2.2% of admissions (1.5e3.2) and an overall estimate of
25,539 patients with at least one HAI annually in Scotland
(16,992e36,977) [6]. There are known methodological issues
with this conversion, so primary data collected with incidence
data are more robust [26e28]. This means that previous inci-
dence estimates derived from the prevalence HAI from every
person in every ward, on any given day, across the NHS are an
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Figure 2. (A) Incidence of HAIs by type per 100,000 acute occupied bed-days (AOBDs) by month of onset. (B) Days from date of admission
to onset of HAI start from 1083 HAIs. HAI, healthcare-associated infection; BSI, bloodstream infection; GI, gastrointestinal infection; LRI,
lower respiratory tract infection; PN, pneumonia; SI, surgical site infection; UTI, urinary tract infection. Thirty-three cases were
excluded, as date of onset and date of admission were not available.
S. Stewart et al. / Journal of Hospital Infection 114 (2021) 10e22 17proportion of the hospital population each year and therefore
total costs are less than previously reported [7,29].
The rank order of HAI types was similar to the Scottish Point
Prevalence Survey (PPS), which was performed betweenSeptember and November 2016 [7]. BSI ranked higher in this
incidence study. This is important because these HAIs have a
high impact on morbidity and mortality [30]. The difference in
rank order will be in part due to the limitations of prevalence
Table V
Estimated number of HAIs in Scotland extrapolated from ECONI using hospital and specialty incidence
HAI type Incidence of HAI types in Scotland Estimate of annual no. of HAIs in Scotland
Rate per 100,000
occupied bed-days
95% CI Estimate 95% CI
All HAIs 187.2 176.8e197.6 7437 7021e7849
Bloodstream infection 35.0 31.3e39.5 1389 1245e1570
Gastrointestinal infection 31.6 28.2e36.3 1256 1122e1440
Lower respiratory tract 26.2 23.6e30.7 1041 937e1218
Pneumonia 15.9 13.7e19.2 630 544e764
Surgical site infection 25.8 22.8e30.5 1023 904e1210
Urinary tract infection 41.0 36.6e46.2 1628 1454e1836
Other 12.0 9.5e15.8 475 378e628
HAI, healthcare-associated infection; CI, confidence interval; ECONI, Evaluation of Cost of Nosocomial Infection study.
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prevalent infections and bias in prevalence surveys towards
those patient populations with longer length of stay (LOS). The
causative organisms in both studies are very similar, with E. coli
being the most common isolate, followed by S. aureus. Dif-
ferences will also be due to the variation in incidence of certain
organisms at different times of year. For example, norovirus
was ranked fourth in order within the ECONI data set but does
not appear in the top ten organisms within the prevalence
survey. This has implications for choosing the best time for PPS
studies in the future.
The origins of HAI show very similar patterns to those
reported within the European PPS [6] (Table IV). This study
reported a greater proportion of patients with vascular cath-
eters present before developing BSI (95.1%) compared with the
European prevalence survey, which reported 57.3% of cases
having vascular catheters in place 48 h before the BSI onset.
This is likely due to the limitations of prevalence survey
methodologies with respect to the consistency of recording
device use. The common use of vascular catheters within
patients with BSI and the fact that 7.3% of BSIs were shown to
be microbiologically linked to catheter use supports the case
for the continued focus on existing vascular catheter-related
infection prevention [31,32]. However, the majority of BSIs
were not linked with devices and so there is a need also to
further develop effective prevention measures for the most
common BSI organisms (E. coli and S. aureus).
For E. coli the resistance percentages were broadly similar to
the bacteraemia isolates reported in the Scottish national data
[33]. Enterococci showed a higher proportion of resistance than
reported within the Scottish One Health Antimicrobial Use and
Antimicrobial Resistance (SONAAR) report for E. faecalis and for
glycopeptide resistance in E. faecium. K. pneumoniae showed
similar patterns of resistance to those shown for all isolates
within the SONAAR report. Pseudomonas aeruginosa showed
increased resistance tomeropenemandpiperacillin/tazobactam
in the small number of samples from which it was isolated.
The rank order of primary HAI with a secondary BSI was very
similar to the PPS with the most common in both studies being
UTIs and GIs. Primary prevention strategies focused on UTI will
not only reduce the overall number of patients with HAI but
may be helpful in preventing BSI, even though only 5.8% of BSI
had a laboratory confirmed primary UTI. Of patients who
developed UTI, 37.8% had a urinary catheter within the 7 days
preceding the UTI, which shows that there is a large proportionof patients who are not exposed to catheter use but who go on
to develop UTI. This is important since successive PPS studies
across Europe have identified UTI as a large burden and yet few
countries have any IPC prevention activity other than that
which is associated with catheter-associated urinary tract
infection [6,34,35]. It may be that primary infection treatment
should be the focus to prevent BSI [36]. Pneumonia contributes
9.4% of all HAI but within this study only 40% of patients were
intubated within 48 h of onset, so this again reinforces the need
for wider IPC measures to be implemented for healthcare-
associated pneumonia [37,38].
Many countries have implemented national surveillance
programmes and report SSI and ICU incidence data; some
report BSI only in the ICU settings. In all cases, administrative
registers are used for denominators and thus there are chal-
lenges in comparing these data [39e41]. Reporting of BSI
incidence is dependent on case definitions, denominators, and
methods, which differ in each surveillance data set. Due to this
lack of consistency in surveillance reporting it is challenging to
compare with other studies. Whereas the incidence of BSI may
appear high within this study, BSI incidence reported here
includes central line-associated bloodstream infection
(CLABSI) along with bloodstream infections associated with
other primary infections and those with undefined sources that
meet the ECDC case definitions. A recent review has also
indicated that CLABSI is likely underreported nationally when
compared to expert review using consistently applied case
definitions [42]. The specialties with the highest recorded
incidence per 100,000 bed-days were ICU, renal medicine, and
cardiothoracic surgery (Figure 1). Patients treated within these
specialties are exposed to a range of interventions which are
known to increase risk of HAI, for example a range of devices
and intubation [43,44]. These high-incidence specialties treat
a relatively small number of patients, and thus only contribute
a smaller proportion of the total HAI cases. This is one of the
challenges in relying on prevalence data alone, in that prior-
ities may be given to high-volume areas rather than to high-risk
specialties or patients [45]. The incidence within the large
teaching hospital is greater than within the general hospital.
Some of this is due to the difference in specialty mix between
the two hospitals and the severity of cases being treated within
the teaching hospital. The highest incidence specialties within
both hospitals were ICUs: the teaching hospital has 25 ICU beds
and 34 high-dependency beds compared with five and four,
respectively, within the general hospital [13].
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vention and control teams. Although certain specialties treat
patients who are at increased risk of HAI, cases are distributed
throughout all of the specialties served by the hospital, and to
effectively ensure patient safety both the high-incidence and
high-volume clinical settings should have appropriate IPC
measures. Within high-incidence settings the benefit of
implementing more complex or costly IPC interventions at a
specialty level may have a greater benefit due to the number of
HAI cases which could be prevented.
There are important findings in these data, related to sea-
sonality and origin of HAI, which require consideration for IPC
planning locally and nationally. Although only 5.1% of HAIs were
present on admission to the study hospitals, 40% of these HAIs
had originated in another hospital and one in ten of those from
outside Scotland (Table IV). This provides important intelli-
gence for consideration of network analysis in IPC planning and
the importance of communications, at the system level, to
manage HAI risk [46]. Understanding the referral networks
within the system and dispersal of HAI, in patient movement
and transfers, may offer a more integrated way of IPC planning.
Strategic planning and information sharing at a systems level
across healthcare networks are a key consideration for future
IPC. The second issue is seasonality of HAI (Figure 2). This study
points to some novel findings around the seasonality of pneu-
monia e LRI, SSI, and GI infection types being higher in the
summer months, alongside the known issue of winter norovirus.
The findings here also point to the importance of taking
account of limitations of microbiology, risks, and seasonality in
future PPS planning, especially if these data are to be used for
estimating impact on length of stay and costs.
This study has limitations. Infections without laboratory-
confirmed HAI may be underrepresented. Within this study,
microbiology tests were used as an indicator of potential HAI
for the research nurses to review against the case definitions;
the samples sent to the laboratory by clinical staff may have
varied dependent on infection type or clinical setting. A
clinical symptom review of each patient admission could
provide a more sensitive result, but this would require a daily
review of each patient’s notes. Underrepresentation of
infections without laboratory confirmation is more likely to
affect the diagnosis of pneumonia than other conditions,
although ICU pneumonias are more likely to have laboratory
samples [25]. UTIs may be underrepresented as some
patients are unable to fully articulate signs and symptoms
required to diagnose not microbiologically confirmed symp-
tomatic HAI. As with all surveillance studies, there is a pro-
portion of clinical infections being treated and managed as
HAI without meeting the case definitions. This study only
describes the epidemiology of the year in which the study
was conducted; there are shifts in patient population and
hospital epidemiology over time. Extrapolation of results
from the two study hospitals to all acute hospitals in Scotland
relies on the assumption that the two study hospitals are
representative of hospitals of the same type. This was
addressed by comparing the incidence rates in the study year
with the prevalence reported in the last Scottish HAI PPS and
examining routine data on hospital size, specialty dis-
tribution, and demographics [7,47,48]. The estimates for
some of the individual HAI subtypes were also verified by
comparing the estimated incidence from the ECONI study
with previously published national data [49]. In both casessimilar rates were obtained, providing evidence that the
chosen approach was valid.
In conclusion, this is the most comprehensive study of
incidence surveillance, across whole hospital populations and
all types of HAI and their impact, performed anywhere in the
UK for more than 20 years [23]. It is the first study of its kind in
Scotland. With the addition of record linkage methods, it
provides HAI estimates of country-level incidence. Studies of
this type are rarely undertaken within whole hospital settings
for a full year due to the cost and time required, and therefore
HAI prevalence surveys have become the standard for esti-
mating HAI burden during the last decade in Scotland, the UK,
and Europe. This incidence study contributes important intel-
ligence on HAI for local and national planning of IPC inter-
ventions, policy, and practice.
National and local IPC efforts over the last decade have
rightly focused on the evidence-based prevention potential in
device-related HAI. This study found a low incidence of device-
related HAI in patients with HAI, but a high incidence of vas-
cular device use, and thus continued value management in
identifying IPC priorities should be considered. Consideration
should be given to the oldest and highest-risk patients in hos-
pital for whom the health impact of HAI would be greatest.
Through knowledge and experience, clinical teams identify
patients who are at particular risk of HAI from the start of their
admission but intelligence on risk from incidence studies can
be used at a hospital level to support planning and imple-
mentation of IPC measures. In addition, the adoption of a
‘system thinking’ approach may be helpful in managing those
at high risk, those likely to have a long stay, and those effec-
tively managing discharge planning to minimize transmission
risk in and between hospitals and long-term care facilities as
highlighted by the recent COVID-19 pandemic. These issues are
of particular concern for patients at risk of antimicrobial
resistance (AMR) infections and those who require frequent
hospital care. The ECONI study has produced a data set using
standard case definitions that can be used for further analysis
and can support consideration of targeted IPC measures in the
future. The intelligence from this study can also be used for
future prevalence surveys to support HAI and AMR burden
estimates.
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